Sectors & IndustriesHealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2025)
Top medical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Industry: Medical Instruments & Sup...
B
Medical is Zen Rated B and is the 54th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
INFU
INFUSYSTEM HOLDINGS INC
$130.26MN/A0.00%N/AN/AN/AN/A
EMBC
EMBECTA CORP
$558.71M4.71%66.70%$0.1500$0.4580%0
XRAY
DENTSPLY SIRONA INC
$3.11B3.07%-14.20%$0.1600$0.4863%02025-06-272025-07-11
ICUI
ICU MEDICAL INC
$3.25BN/A0.00%N/AN/AN/AN/A
MMSI
MERIT MEDICAL SYSTEMS INC
$5.49BN/A0.00%N/AN/AN/AN/A
KRMD
KORU MEDICAL SYSTEMS INC
$149.04MN/A0.00%N/AN/AN/AN/A
PDEX
PRO DEX INC
$129.01MN/A0.00%N/AN/AN/AN/A
NVST
ENVISTA HOLDINGS CORP
$3.13BN/A0.00%N/AN/AN/AN/A
COO
COOPER COMPANIES INC
$13.91BN/A0.00%$0.0075N/AN/A0
BAX
BAXTER INTERNATIONAL INC
$15.71B2.61%-83.60%$0.1700$0.8055%12025-07-01
RGEN
REPLIGEN CORP
$7.16BN/A0.00%N/AN/AN/AN/A
WST
WEST PHARMACEUTICAL SERVICES INC
$15.94B0.37%9.70%$0.2100$0.835%02025-07-302025-08-06
ATRC
ATRICURE INC
$1.57BN/A0.00%N/AN/AN/AN/A
TFX
TELEFLEX INC
$5.30B1.13%41.70%$0.3400$1.3624%02025-06-16
STVN
STEVANATO GROUP SPA
$7.11BN/A0.00%N/AN/AN/AN/A
ANGO
ANGIODYNAMICS INC
$432.87MN/A0.00%N/AN/AN/AN/A
HBIO
HARVARD BIOSCIENCE INC
$22.50MN/A0.00%N/AN/AN/AN/A
WRBY
WARBY PARKER INC
$2.68BN/A0.00%N/AN/AN/AN/A
RMD
RESMED INC
$36.56B0.64%23.20%$0.5300$1.5912%0
HAE
HAEMONETICS CORP
$3.37BN/A0.00%N/AN/AN/AN/A
BLFS
BIOLIFE SOLUTIONS INC
$1.05BN/A0.00%N/AN/AN/AN/A
UTMD
UTAH MEDICAL PRODUCTS INC
$179.17M1.65%32.00%$0.3050$0.9137%12025-06-162025-07-03
ISRG
INTUITIVE SURGICAL INC
$183.57BN/A0.00%N/AN/AN/AN/A
ALC
ALCON INC
$42.73BN/A11.70%N/AN/AN/AN/A
LMAT
LEMAITRE VASCULAR INC
$1.83B0.89%33.70%$0.2000$0.7219%0
ATR
APTARGROUP INC
$9.98B0.89%24.20%$0.4500$1.3519%0
CUPR
CUPRINA HOLDINGS (CAYMAN) LTD
$124.63MN/A0.00%N/AN/AN/AN/A
BDX
BECTON DICKINSON & CO
$49.36B1.76%76.80%$1.0400$3.0339%02025-06-30
AZTA
AZENTA INC
$1.40BN/A0.00%$0.1000N/AN/A0
SMTI
SANARA MEDTECH INC
$256.06MN/A0.00%N/AN/AN/AN/A
STXS
STEREOTAXIS INC
$181.46MN/A0.00%N/AN/AN/AN/A
HOLX
HOLOGIC INC
$14.43BN/A0.00%N/AN/AN/AN/A
BLCO
BAUSCH & LOMB CORP
$4.36BN/A0.00%N/AN/AN/AN/A
STSS
SHARPS TECHNOLOGY INC
$5.55MN/A0.00%N/AN/AN/AN/A
MBOT
MICROBOT MEDICAL INC
$85.12MN/A0.00%N/AN/AN/AN/A
BNGO
BIONANO GENOMICS INC
$12.28MN/A0.00%N/AN/AN/AN/A
LUCY
INNOVATIVE EYEWEAR INC
$7.58MN/A0.00%N/AN/AN/AN/A
KMTS
KESTRA MEDICAL TECHNOLOGIES LTD
$904.25MN/AN/AN/AN/AN/AN/A
PLSE
PULSE BIOSCIENCES INC
$1.06BN/A0.00%N/AN/AN/AN/A
STAA
STAAR SURGICAL CO
$845.91MN/A0.00%N/AN/AN/AN/A
OSUR
ORASURE TECHNOLOGIES INC
$220.66MN/A0.00%N/AN/AN/AN/A
FEMY
FEMASYS INC
$24.22MN/A0.00%N/AN/AN/AN/A
NYXH
NYXOAH SA
$282.20MN/A0.00%N/AN/AN/AN/A
AVR
ANTERIS TECHNOLOGIES GLOBAL CORP
$157.95MN/AN/AN/AN/AN/AN/A
NXGL
NEXGEL INC
$19.60MN/A0.00%N/AN/AN/AN/A
MHUA
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD
$10.88MN/A0.00%N/AN/AN/AN/A
POAI
PREDICTIVE ONCOLOGY INC
$8.57MN/A0.00%N/AN/AN/AN/A
NEPH
NEPHROS INC
$41.02MN/A0.00%N/AN/AN/AN/A
ZTEK
ZENTEK LTD
$148.87MN/A0.00%N/AN/AN/AN/A
POCI
PRECISION OPTICS CORPORATION INC
$36.68MN/A0.00%N/AN/AN/AN/A
RVP
RETRACTABLE TECHNOLOGIES INC
$19.46MN/A0.00%N/AN/AN/AN/A
ZJYL
JIN MEDICAL INTERNATIONAL LTD
$106.92MN/A0.00%N/AN/AN/AN/A
AKYA
AKOYA BIOSCIENCES INC
$61.35MN/A0.00%N/AN/AN/AN/A
EKSO
EKSO BIONICS HOLDINGS INC
$7.44MN/A0.00%N/AN/AN/AN/A
GCTK
GLUCOTRACK INC
$2.72MN/A0.00%N/AN/AN/AN/A
MLSS
MILESTONE SCIENTIFIC INC
$69.06MN/A0.00%N/AN/AN/AN/A

Medical Stocks FAQ

What are the best medical stocks to buy right now in Jun 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best medical stocks to buy right now are:

1. Infusystem Holdings (NYSEMKT:INFU)


Infusystem Holdings (NYSEMKT:INFU) is the #1 top medical stock out of 56 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Infusystem Holdings (NYSEMKT:INFU) is: Value: C, Growth: B, Momentum: D, Sentiment: A, Safety: C, Financials: B, and AI: C.

Infusystem Holdings (NYSEMKT:INFU) has a Due Diligence Score of 24, which is -4 points lower than the medical industry average of 28. Although this number is below the industry average, our proven quant model rates INFU as a "A".

INFU passed 7 out of 33 due diligence checks and has weak fundamentals. Infusystem Holdings has seen its stock lose -6.9% over the past year, overperforming other medical stocks by 44 percentage points.

2. Embecta (NASDAQ:EMBC)


Embecta (NASDAQ:EMBC) is the #2 top medical stock out of 56 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: C, Momentum: D, Sentiment: A, Safety: D, Financials: B, and AI: A.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 7 points higher than the medical industry average of 28.

EMBC passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -26.8% over the past year, overperforming other medical stocks by 24 percentage points.

Embecta has an average 1 year price target of $13.00, an upside of 35.98% from Embecta's current stock price of $9.56.

Embecta stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Embecta, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Dentsply Sirona (NASDAQ:XRAY)


Dentsply Sirona (NASDAQ:XRAY) is the #3 top medical stock out of 56 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Dentsply Sirona (NASDAQ:XRAY) is: Value: B, Growth: C, Momentum: D, Sentiment: A, Safety: B, Financials: C, and AI: C.

Dentsply Sirona (NASDAQ:XRAY) has a Due Diligence Score of 28, which is equal to the medical industry average of 28.

XRAY passed 9 out of 38 due diligence checks and has average fundamentals. Dentsply Sirona has seen its stock lose -41.46% over the past year, overperforming other medical stocks by 9 percentage points.

Dentsply Sirona has an average 1 year price target of $20.50, an upside of 31.16% from Dentsply Sirona's current stock price of $15.63.

Dentsply Sirona stock has a consensus Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Dentsply Sirona, 20% have issued a Strong Buy rating, 20% have issued a Buy, 60% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical stocks with highest dividends?

Out of 10 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Embecta (NASDAQ:EMBC)


Embecta (NASDAQ:EMBC) has an annual dividend yield of 4.71%, which is 3 percentage points higher than the medical industry average of 1.77%.

Embecta's dividend payout ratio of 66.7% indicates that its high dividend yield is sustainable for the long-term.

2. Dentsply Sirona (NASDAQ:XRAY)


Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 3.07%, which is 1 percentage points higher than the medical industry average of 1.77%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -14.2% indicates that its dividend yield might not be sustainable for the long-term.

3. Baxter International (NYSE:BAX)


Baxter International (NYSE:BAX) has an annual dividend yield of 2.61%, which is 1 percentage points higher than the medical industry average of 1.77%. Baxter International's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Baxter International's dividend has shown consistent growth over the last 10 years.

Baxter International's dividend payout ratio of -83.6% indicates that its dividend yield might not be sustainable for the long-term.

Why are medical stocks down?

Medical stocks were down -1.39% in the last day, and down -3.05% over the last week.

We couldn't find a catalyst for why medical stocks are down.

What are the most undervalued medical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued medical stocks right now are:

1. Embecta (NASDAQ:EMBC)


Embecta (NASDAQ:EMBC) is the most undervalued medical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 39 points higher than the medical industry average of 18. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -26.8% in the past year. It has overperformed other stocks in the medical industry by 24 percentage points.

2. Teleflex (NYSE:TFX)


Teleflex (NYSE:TFX) is the second most undervalued medical stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Teleflex has a valuation score of 43, which is 25 points higher than the medical industry average of 18. It passed 3 out of 7 valuation due diligence checks.

Teleflex's stock has dropped -42.7% in the past year. It has overperformed other stocks in the medical industry by 8 percentage points.

3. Haemonetics (NYSE:HAE)


Haemonetics (NYSE:HAE) is the third most undervalued medical stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Haemonetics has a valuation score of 43, which is 25 points higher than the medical industry average of 18. It passed 3 out of 7 valuation due diligence checks.

Haemonetics's stock has dropped -18.55% in the past year. It has overperformed other stocks in the medical industry by 32 percentage points.

Are medical stocks a good buy now?

43.59% of medical stocks rated by analysts are a strong buy right now. On average, analysts expect medical stocks to rise by 28.91% over the next year.

2.27% of medical stocks have a Zen Rating of A (Strong Buy), 15.91% of medical stocks are rated B (Buy), 65.91% are rated C (Hold), 9.09% are rated D (Sell), and 6.82% are rated F (Strong Sell).

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is 38.52x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.